21 results
8-K
EX-99.1
ZOM
Zomedica Corp
26 Feb 19
Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results
4:13pm
in water on the ZM-020 platform
° Commenced initial testing on ZM-024 targeting five initial assay candidates to detect certain thyroid and adrenal
8-K
EX-99.1
ZOM
Zomedica Corp
20 Dec 18
Other Events
5:06pm
in water including seven different gram positive and gram negative bacteria species and three types of crystals with greater than 93.93 percentsensitivity … ” water samples to automated detection of these signatures in urine samples. If development work progresses as anticipated, we expect to commence
8-K
EX-2.1
sx4867
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-2.1
v8qj7iftj gscs4fa
21 Jun 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-2.1
moedurq
1 Oct 21
Zomedica Acquires PulseVet
4:15pm
8-K
EX-1.1
ka7mwd0f
9 Feb 21
Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares
5:22pm
8-K
EX-10.2
t7cfm3fg6hm
8 Apr 20
Zomedica Pharmaceuticals Corp. Announces Public Offering
4:40pm
8-K
EX-10.2
uad6h3ow6ty
6 Jul 20
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
5:18pm
8-K
EX-10.1
i6xcwsho0xydxqhhqd
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
269aqisf i2
13 Feb 20
Zomedica Announces $2.5 Million Registered Direct Offering
12:00am